{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Consultation-liaison psychiatry",
      "Depression",
      "D\u00e9pression",
      "Neuromodulation",
      "Pharmacologie",
      "Pharmacology",
      "Psychiatrie de liaison",
      "Traitement",
      "Treatment"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34256970",
  "DateCompleted": {
    "Year": "2021",
    "Month": "11",
    "Day": "24"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "05",
    "Day": "31"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "07",
        "Day": "10"
      }
    ],
    "Language": [
      "fre"
    ],
    "ELocationID": [
      "10.1016/j.revmed.2021.06.012",
      "S0248-8663(21)00551-8"
    ],
    "Journal": {
      "ISSN": "1768-3122",
      "JournalIssue": {
        "Volume": "42",
        "Issue": "10",
        "PubDate": {
          "Year": "2021",
          "Month": "Oct"
        }
      },
      "Title": "La Revue de medecine interne",
      "ISOAbbreviation": "Rev Med Interne"
    },
    "ArticleTitle": "[Treatments for depression in consultation-liaison psychiatry: From theory to practice].",
    "Pagination": {
      "StartPage": "694",
      "EndPage": "706",
      "MedlinePgn": "694-706"
    },
    "Abstract": {
      "AbstractText": [
        "Treatments for depression include an adapted lifestyle, physical activity, psychotherapies, antidepressant and mood stabilizing drugs, neuromodulation, chronotherapy, spa treatments. Drug treatments used for major depressive episode are antidepressants and mood stabilizers. For a mild episode, psychotherapy is indicated. It should be combined with an antidepressant (serotonin reuptake inhibitor) for moderate and severe episodes. Suicide risk assessment is essential throughout the depressive episode. It is recommended to monitor at the start of antidepressant treatment for suicidal behavior, a change in mood suggesting an underlying bipolar disorder. The effectiveness of the treatment is evaluated after 4 to 8 weeks. The total duration of antidepressant treatment for an EDC is between 6 months and 1 year after remission, in order to prevent relapses. The use of liaison psychiatry, a real healthcare system within the general hospital, is strongly recommended for better screening and treatment of depression, thus reducing the length of hospital stays, improving the prognosis of depression. The aim of this article is to provide clinicians with a summary of validated data on the efficacy/tolerance of treatment for depression, and to suggest practical action to be taken on the main daily clinical situations: treating comorbid conditions, taking into account interactions drugs, manage the serotonin syndrome, lead to withdrawal from antidepressants, manage treatment in the elderly."
      ],
      "CopyrightInformation": "Copyright \u00a9 2021 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Nantes Universit\u00e9, CHU Nantes, Movement, Interactions, Performance (MIP), EA 4334,University of Nantes, Nantes, France. Electronic address: anne.sauvaget@chu-nantes.fr."
          }
        ],
        "LastName": "Sauvaget",
        "ForeName": "A",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "CHU Nantes, Department of Addictology and Liaison Psychiatry, Nantes, France."
          }
        ],
        "LastName": "Guitteny",
        "ForeName": "M",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "CHU Nantes, Department of Addictology and Liaison Psychiatry, Nantes, France."
          }
        ],
        "LastName": "Bukowski",
        "ForeName": "N",
        "Initials": "N"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "CHU Nantes, Department of Addictology and Liaison Psychiatry, Nantes, France; Centre Hospitalier Loire Vend\u00e9e Oc\u00e9an (CHLVO), Psychiatrie de liaison, boulevard Gu\u00e9rin, 85300 Challans, France."
          }
        ],
        "LastName": "Duffieux",
        "ForeName": "V",
        "Initials": "V"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Centre Hospitalier Loire Vend\u00e9e Oc\u00e9an (CHLVO), Psychiatrie de liaison, boulevard Gu\u00e9rin, 85300 Challans, France."
          }
        ],
        "LastName": "Mezouari",
        "ForeName": "A",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "CHU Nantes, Department of Addictology and Liaison Psychiatry, Nantes, France."
          }
        ],
        "LastName": "Brisson",
        "ForeName": "A",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "UPRES, EA 4638, d\u00e9partement de psychiatrie et d'addictologie, universit\u00e9 d'Angers, CHU d'Angers, Angers, France."
          }
        ],
        "LastName": "Raveneau",
        "ForeName": "C",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "UPRES, EA 4638, d\u00e9partement de psychiatrie et d'addictologie, universit\u00e9 d'Angers, CHU d'Angers, Angers, France."
          }
        ],
        "LastName": "Gohier",
        "ForeName": "B",
        "Initials": "B"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "CHU Nantes, Department of Addictology and Liaison Psychiatry, Nantes, France; Inserm-U1246 SPHERE University of Nantes and University of Tours, Nantes, France."
          }
        ],
        "LastName": "Bulteau",
        "ForeName": "S",
        "Initials": "S"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ],
    "VernacularTitle": "Les traitements de la d\u00e9pression en psychiatrie de liaison\u00a0: de la th\u00e9orie \u00e0 la pratique."
  },
  "MedlineJournalInfo": {
    "Country": "France",
    "MedlineTA": "Rev Med Interne",
    "NlmUniqueID": "8101383",
    "ISSNLinking": "0248-8663"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antidepressive Agents"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antidepressive Agents"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Depression"
    },
    {
      "QualifierName": [
        "diagnosis",
        "epidemiology",
        "therapy"
      ],
      "DescriptorName": "Depressive Disorder, Major"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Psychiatry"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Referral and Consultation"
    }
  ]
}